Self-limiting severe neutropenia in a patient with COVID-19

BMJ Case Rep. 2021 Nov 30;14(11):e247057. doi: 10.1136/bcr-2021-247057.

Abstract

Neutropenia is a rare haematological complication of COVID-19 infection in immunocompetent patients. There is sparse literature on neutropenia in patients with COVID-19, except a few case reports. We encountered a similar case in an intensive care unit that developed severe neutropenia on day 24 of illness. Neutropenia resolved spontaneously on 4th day of its appearance. The patient was isolated and kept under close observation, antibiotics were upgraded and strict asepsis was maintained. Thus, we observed in a patient with no comorbidities and uncomplicated neutropenia that strict measures to prevent infection may suffice and the undue risk of hematopoietic therapy can be avoided. An expert opinion should always be sought in such cases as the presence of complications may require an aggressive approach.

Keywords: COVID-19; haematology (incl blood transfusion); intensive care.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • COVID-19*
  • Humans
  • Intensive Care Units
  • Neutropenia* / chemically induced
  • Neutropenia* / drug therapy
  • SARS-CoV-2

Substances

  • Anti-Bacterial Agents